Evaluation of serum levels of visfatin and resistin alongside other biochemical indicators in breast cancer
Zanco Journal of Medical Sciences · 10.05.2026 · 30 (1) · 190-200
DOI: 10.15218/zjms.2026.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zanco Journal of Medical Sciences, online erschienen am 23.04.2026. Verfasst von Nahla Abdullah und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background and objective: One important modifiable risk factor for breast cancer is obesity. The pathophysiology and advancement of breast cancer are facilitated by the release of chemicals from obese adipose tissue, including proinflammatory and adipocytokines. The two adipocytokines that are the subject of this study are Resistin and Visfatin. To compare breast cancer patients' blood and tissue levels of Resistin, Visfatin, and other biochemical markers to those of healthy controls. Methods: a case-control study involving breast cancer patients and healthy individuals. The study included 30 women patients with breast cancer before treatment, the same number (30) of women with breast cancer on treatment, and also 30 women in a healthy group, totally collected 90 female blood sample from patients that diagnosed with a breast cancer and healthy control, the level of serum Visfatin and Resistin with biochemical parameters was performed for all participants.
Results
The mean ± SE Visfatin levels in the patients (pre-treatment and post-treatment) were elevated (4.44 ± 0.807, 7.79 ± 1.802) relative to the control (3.53 ± 0.214). With a P-value of 0.025. There was a significant difference in the mean ± SE of serum Resistin levels between the cases and the control group with (P = 0.013).
Conclusion
According to our study, women with breast cancer had significantly greater levels of Visfatin and Resistin than those in good health. This implies that the genesis and progression of breast cancer may be influenced by these adipocytokines. Keywords: Breast cancer, Lipid profile, Resistin, Visfatin.
Zitieren
APA
Abdullah, N., & Ahmad, S. (2026). Evaluation of serum levels of visfatin and resistin alongside other biochemical indicators in breast cancer. Zanco Journal of Medical Sciences, 30(1), 190-200. https://doi.org/10.15218/zjms.2026.014
Vancouver
Abdullah N, Ahmad S. Evaluation of serum levels of visfatin and resistin alongside other biochemical indicators in breast cancer. Zanco Journal of Medical Sciences. 2026;30(1):190-200. doi:10.15218/zjms.2026.014
BibTeX
@article{Abdullah2026,
author = {Abdullah, Nahla and Ahmad, Sardar},
title = {Evaluation of serum levels of visfatin and resistin alongside other biochemical indicators in breast cancer},
journal = {Zanco Journal of Medical Sciences},
year = {2026},
volume = {30},
number = {1},
pages = {190--200},
doi = {10.15218/zjms.2026.014}
}
EUVIMED